Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -2.10%-1.32M | 47.51%-673.86K | 223.49%702.82K | -73.05%-5.78M | -84.52%-2.63M | 21.32%-1.29M | -867.65%-1.28M | -29.58%-569.11K | 54.67%-3.34M | -164.64%-1.43M |
| Net income from continuing operations | -59.14%-2.82M | -20.09%-2.96M | -25.07%-3.1M | 4.68%-10.13M | -229.42%-3.41M | 34.92%-1.77M | 45.68%-2.47M | -6.57%-2.47M | 11.03%-10.62M | -236.16%-1.04M |
| Operating gains losses | 51.11%-66 | ---- | ---- | 414.88%277K | 2,661.43%282.5K | 66.42%-135 | ---- | ---- | 93.32%-87.97K | ---11.03K |
| Depreciation and amortization | 8.57%840.59K | -7.78%795.89K | -20.78%744.27K | -9.05%3.29M | -25.58%715.98K | -12.68%774.27K | -6.70%863.01K | 10.97%939.54K | 10.40%3.62M | 5.92%962.09K |
| Asset impairment expenditure | 269.09%60.53K | 118.81%39.47K | 112.30%144.28K | -217.21%-167.02K | 104.42%10.62K | -125.22%-35.8K | -191.33%-209.8K | 519.69%67.96K | 152.77%142.5K | 75.15%-240.12K |
| Remuneration paid in stock | ---- | ---- | ---3.76K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Remuneration paid in stock | 136.65%111.27K | -67.28%33.67K | 9.23%31.66K | -111.51%-98.5K | -67.47%73.17K | -243.06%-303.58K | -51.50%102.93K | -85.94%28.98K | -46.19%855.53K | -45.73%224.95K |
| Other non cashItems | 38.41%1.34M | 102.08%1.54M | 108.09%1.66M | 107.13%4M | 385.05%1.48M | 180.45%964.82K | -60.41%759.88K | 329.41%798.43K | -56.40%1.93M | -367.97%-518.14K |
| Change In working capital | 8.01%-842.3K | 64.67%-115.71K | 1,621.44%1.22M | -458.45%-2.95M | -120.11%-1.78M | -83.66%-915.65K | -121.85%-327.5K | -88.81%70.89K | 126.29%824.15K | -51.85%-809.57K |
| -Change in receivables | 71.83%-124.84K | 117.12%38.27K | -536.92%-315.81K | -661.32%-1.32M | -644.13%-600.78K | -1,142.30%-443.16K | -449.21%-223.46K | -212.03%-49.58K | 26.35%-172.99K | 82.60%-80.74K |
| -Change in inventory | 108.77%360.95K | 238.30%1.65M | 6.44%-674.07K | -5,436.63%-7.39M | -402.32%-1.36M | -568.54%-4.12M | -652.35%-1.19M | -179.00%-720.46K | 89.95%-133.5K | -138.53%-271.41K |
| -Change in prepaid assets | 344.12%412.35K | -17.26%-622.82K | 13.66%-95.41K | -1,195.20%-648.76K | -287.84%-99.95K | 161.54%92.85K | -948.82%-531.14K | -217.16%-110.5K | 153.16%59.24K | -77.15%53.21K |
| -Change in payables and accrued expense | -141.99%-1.49M | -172.84%-1.18M | 142.33%2.31M | 497.61%6.4M | 152.69%282.2K | 980.51%3.55M | -1.03%1.62M | 366.57%951.43K | 173.42%1.07M | 46.78%-535.6K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -2.10%-1.32M | 47.51%-673.86K | 223.49%702.82K | -73.05%-5.78M | -84.52%-2.63M | 21.32%-1.29M | -867.65%-1.28M | -29.58%-569.11K | 54.67%-3.34M | -164.64%-1.43M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -184.37%-694K | -10,064.34%-477.72K | -844.11%-586.09K | 35.47%-756.27K | -17.84%-445.44K | 52.37%-244.05K | 92.71%-4.7K | 71.41%-62.08K | 8.11%-1.17M | -1,972.77%-378K |
| Net PPE purchase and sale | -193.38%-693.24K | -10,522.37%-467.17K | -3,152.95%-561K | 40.36%-679.61K | -12.98%-421.67K | 53.31%-236.3K | 89.86%-4.4K | 92.04%-17.25K | 10.50%-1.14M | -1,788.96%-373.23K |
| Net intangibles purchas and sale | 90.20%-759 | -3,394.04%-10.55K | 44.04%-25.09K | -135.19%-76.66K | -398.16%-23.78K | -23.42%-7.75K | 98.57%-302 | -10,182.80%-44.83K | -162.01%-32.59K | -149.37%-4.77K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -184.37%-694K | -10,064.34%-477.72K | -844.11%-586.09K | 35.47%-756.27K | -17.84%-445.44K | 52.37%-244.05K | 92.71%-4.7K | 71.41%-62.08K | 8.11%-1.17M | -1,972.77%-378K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -196.90%-1.32M | 410.54%4.65M | -117.76%-173.03K | 161.39%6.11M | 323.52%2.87M | -24.71%1.36M | 96.98%911.37K | 260.70%974.42K | -52.19%2.34M | -66.14%677.11K |
| Net issuance payments of debt | -151.39%-850.5K | -43.35%540.66K | -95.15%47.94K | 85.22%7.06M | 327.53%3.46M | -7.94%1.66M | -47.30%954.41K | 262.93%987.91K | 299.89%3.81M | 247.12%810.44K |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --6.82M | --0 | --0 | -65.81%9.72K | --0 | --0 | --0 | --9.72K | -74.85%28.43K | 100.00%-1 |
| Interest paid (cash flow from financing activities) | -164.19%-473.5K | ---2.16M | ---197.47K | ---659.44K | ---480.22K | ---179.23K | --0 | --0 | --0 | --0 |
| Net other financing activities | -196.90%-347.08K | -356.59%-196.5K | -1.25%-23.5K | 80.03%-300.08K | 12.30%-116.93K | -5,844,950.00%-116.9K | ---43.04K | ---23.21K | ---1.5M | ---133.33K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -196.90%-1.32M | 410.54%4.65M | -117.76%-173.03K | 161.39%6.11M | 323.52%2.87M | -24.71%1.36M | 96.98%911.37K | 260.70%974.42K | -52.19%2.34M | -66.14%677.11K |
| Net cash flow | ||||||||||
| Beginning cash position | 371.70%4.07M | -54.03%579K | -29.76%633.23K | -70.14%901.55K | -67.34%717.02K | -65.07%862.56K | -29.81%1.26M | -70.14%901.55K | -51.50%3.02M | 123.28%2.2M |
| Current changes in cash | -1,811.34%-3.33M | 1,028.30%3.5M | -116.41%-56.31K | 80.69%-419.32K | 81.27%-211.32K | 49.64%-174.07K | -166.70%-377.17K | 127.18%343.24K | 42.06%-2.17M | -176.18%-1.13M |
| Effect of exchange rate changes | -261.63%-46.1K | 41.34%-11.62K | -85.92%2.08K | 184.34%151K | 177.02%127.53K | -60.26%28.52K | -118.13%-19.8K | -60.92%14.75K | -90.17%53.11K | -129.81%-165.59K |
| End cash Position | -2.99%695.61K | 371.70%4.07M | -54.03%579K | -29.76%633.23K | -29.76%633.23K | -67.34%717.02K | -65.07%862.56K | -29.81%1.26M | -70.14%901.55K | -70.14%901.55K |
| Free cash from | -31.12%-2.01M | 10.63%-1.15M | 118.49%116.72K | -44.85%-6.53M | -70.56%-3.08M | 28.72%-1.53M | -1,353.72%-1.29M | 3.83%-631.19K | 47.86%-4.51M | -247.74%-1.81M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.